hCTLA4-Gene-Modified Human Bone Marrow-Derived Mesenchymal Stem Cells (hBMMSCs) Maintain POSTN Secretion to Enhance the Migration Capability of Allogeneic hBMMSCs through the Integrin <i>α</i>v<i>β</i>3/FAK/ERK Signaling Pathway

<div>hBMMSCs and allo-hBMMSCs were successfully isolated. Cell proportions of stem cell positive markers (CD44, CD105, and CD90) and stem cell negative markers (CD34 and CD45) were identified by the flow cytometric analysis.</div>

Stem Cells International

fig1

Figure 1

Figure 1: hCTLA4-Gene-Modified Human Bone Marrow-Derived Mesenchymal Stem Cells (hBMMSCs) Maintain POSTN Secretion to Enhance the Migration Capability of Allogeneic hBMMSCs through the Integrin <i>α</i>v<i>β</i>3/FAK/ERK Signaling Pathway 

Figure 1 | hCTLA4-Gene-Modified Human Bone Marrow-Derived Mesenchymal Stem Cells (hBMMSCs) Maintain POSTN Secretion to Enhance the Migration Capability of Allogeneic hBMMSCs through the Integrin αvβ3/FAK/ERK Signaling Pathway 